Navigation Links
Human Pheromone Sciences Announces Third Quarter Results
Date:11/13/2008

2008 2007

(Unaudited)

Assets

Cash and cash equivalents $ 1,082 $ 1,437

Accounts receivable 91 194

Inventories 50 25

Other current assets 34 40

Property and equipment, net 2 3

Total $1,259 $ 1,699

Liabilities and shareholders' equity

Accounts payable $31 $28

Other current liabilities 138 141

Deferred income - current 384 518

Deferred income - non-current 375 566

Common stock 21,029 20,963

Accumulated deficit (20,698) (20,517)

Total $1,259 $1,699

HUMAN PHEROMONE SCIENCES, INC.

Condensed Statements of Operations

(Unaudited)

(Dollars in thousands, except per-share data)

Three months Nine months

ended ended

September 30, September 30,

2008 2007 2008 2007

Net revenue $262 $239 $764 $902

Cost of goods sold 86 94 240 277

Research and development 10 10 33 38

Selling, general and administrative 203 240
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans
2. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
4. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
5. Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
6. Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
7. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
8. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
9. Human Pheromone Sciences, Inc. - Shareholder Update
10. The human brain minimizes energy expenditure and integrates gravity in to the action plan
11. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an ... and monetization of intellectual property, today provided an ... and  Spherix v. Uniden , Case No. 3:13-cv-03496-M, ... the Northern District of Texas ... Verizon, Case No. 1:14-cv-00721-GBL-TCB, in the United ...
(Date:3/30/2015)... OXFORD, England , March 30, 2015 /PRNewswire/ ... company developing novel biological drugs to treat cancer, ... appointment of Professor Sir John Bell , ... and Chairman of the Office for the Strategic ... Directors with immediate effect.      (Photo: ...
(Date:3/30/2015)... , March 30, 2015 ... auf    Richmond Pharmacology ist das erste ... Amyloidose-Zentrum am Royal Free Hospital in ... zur Untersuchung eines RNAi-Therapeutikums Studienversuche an einem Patienten ... von Transthyretin vermittelter Amyloidose entwickelt (ATTR), einer seltenen ...
(Date:3/29/2015)... IRVING, Texas , March 29, 2015 /PRNewswire/ ... two studies in which Caris Molecular Intelligence®, the ... molecular similarities and differences between several rare and ... treatment strategies that have the potential to improve ... Poster Session B at the Society of Gynecologic ...
Breaking Biology Technology:Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4
... 7 BioEnergy International, LLC,(BioEnergy), a privately-held, ... and biofuels, announces the,addition of Norman R. ... December,2008. Mr. Augustine has a record of ... of industry and government culminating in his ...
... Vaccine Has Potential to Save Millions of Lives, ... Inc.,(IBT), a biotechnology company focused on development of ... have been awarded a multiyear contract for advanced ... Marburg viruses from the National,Institute of Allergy and ...
... Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a ... today that its distributor,The Oyamo group has place ... (CTLM(R)) for Jerusalem, Israel., (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ... import license from the Israel Ministry of,Health which ...
Cached Biology Technology:BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses 2Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses 3Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel 2
(Date:3/17/2015)... 17, 2015  MecklerMedia Corporation (OTCQX: MECK) announced ... service robots ever held in New ... May 11-13, 2015 at the Javits Convention Center. ... event include: Acorn Product Development; Axis NJ; c-Link ... Robotics; Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; ...
(Date:3/12/2015)... -- Beta Systems today announced Fast ... (IAM) solution for a fixed price and with ... IAM package, customers benefit from the 30 years, ... implementations across different industries. The new fixed-price IAM ... necessary services and consulting. It spans the implementation ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... Italy , May 10, 2010 Health ... security guidelines for controlled substances, including,tamper-evident syringe caps, biometric identification, ... , , , ... "In addition to being the only ...
... A new commentary on the nature of pathogens is raising ... on evolution plays in the understanding of emerging disease. Ecological ... a population shifts onto a novel host, is one of ... in plants, argue the authors of a new paper published ...
... URBANA A recent research study has shown ... amounts of food due to resource constraints, can lead ... woman,s pregnancy. "Prior studies have shown that ... to experience health complications," said Craig Gundersen, a University ...
Cached Biology News:Health Robotics' i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances 2Health Robotics' i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances 3Health Robotics' i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances 4Emergence of fungal plant diseases linked to ecological speciation 2Food insecurity increases risk of weight gain and complications during pregnancy 2
... PBL's bioassays for interferons are cytopathic effect ... assays. Sample types include; tissue culture supernatents; ... In these assays, one unit is defined as ... reduce the cytopathic effect of viral infection by ...
supplied with 10x reaction buffer...
HyPro 20 system for slide hybridization. 20 slide capacity. Active vibration system, slide rack and humidity chamber. Ideal for microarray and in situ hybridization....
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
Biology Products: